Teladoc Health 将来の成長
Future 基準チェック /06
Teladoc Health利益と収益がそれぞれ年間81.5%と0.7%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に-10.9% 86.1%なると予測されています。
主要情報
81.5%
収益成長率
86.1%
EPS成長率
| Healthcare Services 収益成長 | 30.6% |
| 収益成長率 | 0.7% |
| 将来の株主資本利益率 | -10.9% |
| アナリストカバレッジ | Good |
| 最終更新日 | 26 Nov 2024 |
今後の成長に関する最新情報
Recent updates
Teladoc: Maybe This Goose Isn't Cooked Yet (Rating Upgrade)
Nov 27Teladoc Health, Inc. (NYSE:TDOC) Surges 40% Yet Its Low P/S Is No Reason For Excitement
Nov 26
Teladoc Health, Inc. (NYSE:TDOC) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 02Is Teladoc Health (NYSE:TDOC) A Risky Investment?
Oct 23Teladoc: Double-Digit FCF Yield, Possible BetterHelp Transition
Oct 13Teladoc Health, Inc. (NYSE:TDOC) Surges 28% Yet Its Low P/S Is No Reason For Excitement
Sep 18Teladoc Health: Some Negative Things, But One Aspect That Makes Me Feel Positive
Sep 15Teladoc: Prospects Are Ready For Better Health
Sep 04Teladoc Post Q2 Earnings: Stick A Fork In This Stock - It's Nearly Done (For)
Aug 01Teladoc's Vital Signs: Why 5x FCF Means Stable Health (Rating Upgrade)
Jul 22Teladoc Health, Inc.'s (NYSE:TDOC) Revenues Are Not Doing Enough For Some Investors
Jul 17Teladoc Health: Weight Loss Management Could Help
Jul 01Would Teladoc Health (NYSE:TDOC) Be Better Off With Less Debt?
Jun 04Teladoc: Stock Likely To Be Range Bound Until Guidance Is Revised Upwards
May 31Teladoc: Huge Execution Problem
Apr 27Teladoc: Improving Business Trends (Rating Upgrade)
Apr 17Teladoc: Management Has A Lot To Prove To Gain Investor Confidence
Mar 25Teladoc Health, Inc.'s (NYSE:TDOC) 25% Dip In Price Shows Sentiment Is Matching Revenues
Mar 10Teladoc Health: Another Bad Quarter, Another Wave Of Capitulation
Feb 21Teladoc Health: Weight Management Rescue
Jan 21Teladoc Health (NYSE:TDOC) Is Carrying A Fair Bit Of Debt
Jan 15When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?
Dec 12Teladoc Q3: Getting Stronger (Rating Upgrade)
Nov 29Teladoc Health, Inc.'s (NYSE:TDOC) Intrinsic Value Is Potentially 78% Above Its Share Price
Nov 22Teladoc Was Obliterated
Oct 25Is Teladoc Health (NYSE:TDOC) A Risky Investment?
Oct 11Teladoc: Broken Growth Story Deteriorates Further (Rating Downgrade)
Oct 02Teladoc Stock: A Hold Amid New Covid Wave
Sep 14Teladoc's Technical Decline Hints At A Buying Opportunity
Aug 28Is There An Opportunity With Teladoc Health, Inc.'s (NYSE:TDOC) 44% Undervaluation?
Aug 18Buy Teladoc: AI Will Likely Spur Healthcare Deflation
Aug 16Teladoc's Future: Virtual Healthcare, AI, And Valuation
Jul 28Teladoc And Microsoft's Expanded Strategic Partnership Is A Powerful AI Combo
Jul 21The Big Trends: New Frontiers in Healthcare
Jul 13
When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?
Jul 10Teladoc Health: Likely To Remain Out Of Favor
Jun 26Teladoc Health, Inc.'s (NYSE:TDOC) Revenues Are Not Doing Enough For Some Investors
Jun 25Here's Why Teladoc Health (NYSE:TDOC) Can Afford Some Debt
May 25Teladoc: BetterHelp Segment Margins Are Key
May 23Are Investors Undervaluing Teladoc Health, Inc. (NYSE:TDOC) By 20%?
May 06Is It Too Late To Consider Buying Teladoc Health, Inc. (NYSE:TDOC)?
Mar 10業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2026 | 2,589 | -147 | 241 | 364 | 19 |
| 12/31/2025 | 2,542 | -154 | 214 | 344 | 25 |
| 12/31/2024 | 2,569 | -988 | 176 | 308 | 25 |
| 9/30/2024 | 2,590 | -982 | 207 | 338 | N/A |
| 6/30/2024 | 2,609 | -1,006 | 196 | 333 | N/A |
| 3/31/2024 | 2,619 | -233 | 200 | 346 | N/A |
| 12/31/2023 | 2,602 | -220 | 194 | 350 | N/A |
| 9/30/2023 | 2,580 | -4,002 | 112 | 285 | N/A |
| 6/30/2023 | 2,531 | -4,018 | 64 | 243 | N/A |
| 3/31/2023 | 2,471 | -7,054 | 47 | 234 | N/A |
| 12/31/2022 | 2,407 | -13,660 | 17 | 189 | N/A |
| 9/30/2022 | 2,323 | -9,860 | 65 | 207 | N/A |
| 6/30/2022 | 2,234 | -9,871 | 107 | 221 | N/A |
| 3/31/2022 | 2,144 | -6,904 | 99 | 180 | N/A |
| 12/31/2021 | 2,033 | -429 | 130 | 194 | N/A |
| 9/30/2021 | 1,862 | -812 | -54 | -4 | N/A |
| 6/30/2021 | 1,629 | -763 | -92 | -49 | N/A |
| 3/31/2021 | 1,367 | -655 | -102 | -65 | N/A |
| 12/31/2020 | 1,094 | -485 | -80 | -54 | N/A |
| 9/30/2020 | 867 | -110 | 59 | 80 | N/A |
| 6/30/2020 | 716 | -95 | 46 | 61 | N/A |
| 3/31/2020 | 606 | -98 | 19 | 31 | N/A |
| 12/31/2019 | 553 | -99 | 19 | 30 | N/A |
| 9/30/2019 | 520 | -105 | 4 | 14 | N/A |
| 6/30/2019 | 493 | -108 | 2 | 11 | N/A |
| 3/31/2019 | 457 | -103 | -8 | 1 | N/A |
| 12/31/2018 | 418 | -97 | -13 | -5 | N/A |
| 9/30/2018 | 372 | -117 | -22 | -15 | N/A |
| 6/30/2018 | 330 | -125 | N/A | -37 | N/A |
| 3/31/2018 | 280 | -115 | N/A | -36 | N/A |
| 12/31/2017 | 233 | -107 | N/A | -34 | N/A |
| 9/30/2017 | 194 | -77 | N/A | -35 | N/A |
| 6/30/2017 | 157 | -75 | N/A | -38 | N/A |
| 3/31/2017 | 139 | -75 | N/A | -47 | N/A |
| 12/31/2016 | 123 | -74 | N/A | -52 | N/A |
| 9/30/2016 | 108 | -75 | N/A | -57 | N/A |
| 6/30/2016 | 96 | -58 | N/A | -59 | N/A |
| 3/31/2016 | 88 | -61 | N/A | -54 | N/A |
| 12/31/2015 | 77 | -58 | N/A | -47 | N/A |
| 9/30/2015 | 68 | -50 | N/A | -39 | N/A |
| 6/30/2015 | 59 | -42 | N/A | -24 | N/A |
| 3/31/2015 | 51 | -29 | N/A | -19 | N/A |
| 12/31/2014 | 44 | -20 | N/A | -11 | N/A |
| 12/31/2013 | 20 | -10 | N/A | -6 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: TDOC今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: TDOC今後 3 年間、利益が出ない状態が続くと予測されています。
高成長収益: TDOC今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: TDOCの収益 ( 0.7% ) US市場 ( 8.9% ) よりも低い成長が予測されています。
高い収益成長: TDOCの収益 ( 0.7% ) 20%よりも低い成長が予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: TDOC 3 年以内に赤字になると予測されています。